ESMA rebukes FCA for poor handling of derivatives data under EMIR
The FCA has disputed a peer assessment that its analysis and integration of EMIR data in its supervisory approach is not meeting expectations.
Tag: ESMA
ESMA considers expansion of MAR to include spot FX market
Spot FX is currently out of scope of MiFID II and MAR, but ESMA is contemplating bringing the market in scope of the market abuse rules.
ESMA identifies possible liquidity risks in high-yield bond funds
Stress simulation framework finds “pockets of vulnerabilities” in UCITS bond funds in pure redemption shock scenarios.
Consolidated tape effort revived in Europe as ESMA launches consultation
ESMA chair Steven Maijoor says it is time to decide if and how a consolidated tape should be produced in Europe.
MiFID II periodic auctions survive intense regulatory scrutiny
ESMA’s final report on periodic auctions says venues are not used to evade MiFID II dark trading rules, as fears of outright ban are dampened.
Equities
ESMA adjusts share trading obligation plans for no-deal Brexit to ease industry concerns
European regulatory watchdog revises approach to STO for 14 UK stocks after FCA raises alarm over liquidity and market fragmentation under a no-deal scenario.
Technical issue sees ESMA delay crucial MiFID II systematic internaliser data
Systematic internaliser data due to be published on 30 April has been delayed by the European markets regulatory after a technical issue.
Equities
Stocks caught in crossfire of no-deal Brexit share trading plans
Analysis from big xyt shows that some stocks will be caught in the crossfire of a UK share trading obligation, as industry’s concern on EU no-deal Brexit share trading plans heightens.
Equities
ESMA sparks concern with share trading Brexit plans
Major UK stocks including Vodafone and Coca-Cola would have to be traded within the EU in ‘no-deal’ Brexit scenario under the share trading obligation.
ESMA approves DTCC’s trade repository as Bloomberg withdraws registration
DTCC gained approval back in 2013, along with counterparts Regis-TR, UnaVista, CME and ICE.